CER-001 Atherosclerosis Regression ACS Trial

Clinical trial NCT02484378 · COMPLETED

Trial details

NCT number: NCT02484378
Sponsor: Cerenis Therapeutics, SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndromes

Start date: 2015-08-01
Primary completion: 2016-11-01
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.